KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Current Assets (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Current Assets for 4 consecutive years, with $1.1 billion as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Current Assets fell 21.9% year-over-year to $1.1 billion, compared with a TTM value of $1.1 billion through Sep 2023, down 21.9%, and an annual FY2022 reading of $1.5 billion, down 15.84% over the prior year.
  • Current Assets was $1.1 billion for Q3 2023 at Ginkgo Bioworks Holdings, down from $1.2 billion in the prior quarter.
  • Across five years, Current Assets topped out at $1.8 billion in Q3 2021 and bottomed at $966879.0 in Q2 2021.
  • Average Current Assets over 4 years is $1.1 billion, with a median of $1.3 billion recorded in 2023.
  • The sharpest move saw Current Assets surged 57025.62% in 2022, then dropped 22.19% in 2023.
  • Year by year, Current Assets stood at $426.5 million in 2020, then skyrocketed by 303.96% to $1.7 billion in 2021, then dropped by 15.84% to $1.5 billion in 2022, then decreased by 21.26% to $1.1 billion in 2023.
  • Business Quant data shows Current Assets for DNA at $1.1 billion in Q3 2023, $1.2 billion in Q2 2023, and $1.3 billion in Q1 2023.